Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison Between Low Mixed Insulin and Mid Mixed Insulin AS Starter Insulin For Patients With TYpe 2 Diabetes Mellitus (CLASSIFY Study)

Trial Profile

Comparison Between Low Mixed Insulin and Mid Mixed Insulin AS Starter Insulin For Patients With TYpe 2 Diabetes Mellitus (CLASSIFY Study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2018

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms CLASSIFY
  • Sponsors Eli Lilly
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Jun 2018 Results of a post-hoc analysis assessing the contribution of fasting blood glucose and/or postprandial glucose in overall glycemic control in Chinese patients under insulin treatment, published in the Diabetes Therapy.
    • 09 Jun 2015 Results (China subgroup analysis) presented at the 75th Annual Scientific Sessions of the American Diabetes Association (n = 156).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top